Announcements - Pharmacogenomics Research and Personalized Medicine

Posted: 2023-03-15

Full implementation of transparent peer review at Pharmacogenomics Research and Personalized Medicine

With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, our editorial office has decided to fully implement the transparent peer review (TPR) process for all new submission from March 15, 2023.

Posted: 2020-04-29

AME entered an official partnership with Publons to enhance wide-ranging recognition for reviewers

AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020.

Posted: 2019-10-15

Application of the CARE Guideline as reporting standard in Pharmacogenomics Research and Personalized Medicine

Pharmacogenomics Research and Personalized Medicine welcomes case reports which are supposed to report new observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in the fields of medicine.